URN zum Zitieren dieses Dokuments: urn:nbn:de:bvb:355-epub-254491
Coleman, R. J., Lange, Klaus W., Quinn, N. P., Loper, A. E., Bondi, J. V., Hichens, M., Stahl, S. M. und Marsden, C. D.
The antiparkinsonian actions and pharmacokinetics of transdermal (+)-4-propyl-9-hydroxynaphthoxazine (+PHNO): preliminary results.
Movement disorders 4 (2), S. 129-138.
Zum PubMed-Eintrag dieses Artikels
Zum Artikel beim Verlag (über DOI)
(+)-4-Propyl-9-hydroxynaphthoxazine (+PHNO) is a potent dopamine agonist that has been administered transdermally to four patients with Parkinson's disease and "on-off" fluctuations. Skin patches of increasing size were used to treat these patients, who also received infrequent doses of oral levodopa if required. The effect of +PHNO was measured as an increased duration of action of individual ...
Bibliographische Daten exportieren